Zurich University
of Applied Sciences

Health Technology Assessment: Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis

Key data

Project team

Cécile Grobet, Maxim Sharakin, Linda Vinci, Maria Carlander, Flurina Meier, Prof. Dr. Philipp Egli, Prof. Dr. Andreas Gerber-Grote, Prof. Dr. Simon Wieser

Project status

completed, 01/2020 - 10/2021

Institute/Centre

Winterthur Institute of Health Economics (WIG); School of Health Sciences; Institute of Enterprise Law (IUR)

Funding partner

Bundesamt für Gesundheit BAG / Sektion Health Technology Assessment (HTA)

Project budget

165'000 CHF

Portrait photo of Cécile Grobet

Cécile Grobet

School of Management and Law
Gertrudstrasse 8
8400 Winterthur

+41 (0) 58 934 66 25
cecile.grobet@zhaw.ch

go back

Privacy Settings

Here we show you which services may run on our website. You decide for yourself which services we may use. You can find more information in our privacy notice.

Our website needs these cookies so that everything works properly. These cookies are created automatically when you are active on the site – for example, when you change privacy settings or fill in forms. You can block these cookies in your browser or set it to warn you about them, but some parts of the website will then no longer display correctly. These cookies do not store any of your personal data.

These services allow us to see how our website is used, but we do not know who you are. By activating these services, you help us make the website better for everyone.